LABOR COURSE AND CONDITION OF NEWBORNS IN WOMEN WITH PLACENTAL DYSFUNCTION DUE TO GESTATIONAL ENDOTHELIOPATHY by V. V. Lazurenko et al.
WORLD SCIENCE                                                                                                                          ISSN 2413-1032 
 





LABOR COURSE AND CONDITION OF NEWBORNS IN 
WOMEN WITH PLACENTAL DYSFUNCTION DUE TO 
GESTATIONAL ENDOTHELIOPATHY 
 
1Prof., MD V. V. Lazurenko  
²Post-graduate student I. B. Borzenko  
3Post-graduate student D. Yu. Tertyshnik  
Ukraine, Kharkiv, Kharkiv National Medical University 
1Head of t Department of Obstetrics and Gynecology No. 2 





Received: 16 July 2019 
Accepted: 10 September 2019 
Published: 30 September 2019 
 ABSTRACT 
The purpose of the study is to evaluate the effect of placental dysfunction 
caused by gestational endotheliopathy on the course of labor and the 
condition of the newborn. The first group consisted of 70 patients with 
placental dysfunction with gestational endotheliopathy confirmed by 
laboratory-instrumental findings in the first trimester of pregnancy. The 
control group included 30 pregnant women with physiological gestational 
course. PD secondary to GE leads to preterm birth, fetal distress, increases 
the percentage of caesarean section, contributes to the delay of fetal growth 
and birth weight, poor infant status and perinatal complications. 
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Introduction. Placental dysfunction (PD) remains one of the urgent problems of obstetrics, 
occuring in 15-35% of women in physiological pregnancy and in 24-80% of women with obstetric and 
extragenital abnormalities, reaching 40% in the structure of complications of pregnancy with no 
tendency to decrease and is the basis of high level of perinatal morbidity and mortality, disorders of 
neuropsychic development and adaptation of children [3,5,7]. 
Despite the introduction of new methods of PD diagnosis and prevention into obstetric practice, a 
clear tendency to decrease its incidence is not observed, and this problem continues to be relevant in 
modern obstetrics. Defective placentation and, as a consequence, PD is the direct cause of what is called 
“major obstetric syndromes”: preeclampsia, fetal growth retardation syndrome (FGR), preterm birth, 
premature rupture of the membranes, premature placental abruption [8, 10]. PD should be considered as a 
clinical syndrome associated with morpho-functional changes in the placenta, due to disorders of 
compensatory and adaptive properties in the “mother-placenta-fetus” system [1, 9]. PD is characterized by 
a complex of disorders of trophic, transport, endocrine and metabolic function of the placenta, which 
underlie the development of pathology of the fetus and newborn [4, 8]. The nature and extent of the impact 
of different pathologies during pregnancy on the fetus is determined by various factors: gestation time, 
duration of exposure, condition of the feto-placental complex [1]. 
In recent years, the problem of gestational endotheliopathy (GE) - the violation of vasodilating, 
angioprotective, antiproliferative functions of emerging endothelium during pregnancy - is of great interest. 
As a result, the following occur: discoordination of vascular tone; activation of proliferative processes of 
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the vascular wall; changes in the structure and number of endothelial cells; the property of the inner surface 
of the vascular wall adhesive properties [2, 6]. 
Studies of the role of GE in the development of perinatal pathology and methods of prevention 
of obstetric complications are very few, extremely controversial and contain different views on the 
problem. In view of the above, it is advisable to study the clinical and morphological, markers of 
vascular wall thrombogenicity and factors of regulation of adhesive substances of endothelial origin in 
gestational endotheliopathy. However, the focus of modern clinicians is on some measures in placental 
dysfunction that will improve the prognosis of gestation, the occurrence of PD, to develop a 
personalized strategy for optimal term and mode of delivery, and as a consequence, to prevent the 
development of obstetric and early neonatal disorders. 
The purpose of the study is to reduce the incidence of perinatal complications in women with placental 
dysfunction based on a study of the effect of gestational endothelial disease on labor and neonatal status. 
Materials and methods. The first (main) group consisted of 70 patients with placental dysfunction 
and gestational endotheliopathy confirmed by laboratory-instrumental findings (MAU greater than 5 mg 
albumin / mmol creatinine and EDV less than 10%) in the first trimester of pregnancy. Whereas the second 
(control) group comprised 30 pregnant women with physiological gestational course without placental 
dysfunction, with no endothelial dysfunction, whose clinical and laboratory parameters were the control 
ones for comparing the examination data of pregnant women with PD of the main group. 
Given the different genesis of placental dysfunction, to clarify the contribution of risk factors to 
the development of this pathological condition, the main group was divided into 2 subgroups: subgroup 
A - 40 patients with PD and fetal growth retardation syndrome (FGR) and subgroup B - 30 pregnant 
women with PD and without FGR. 
PD was detected according to the clinical course of pregnancy, the results of ultrasound and 
Doppler examination of pregnant women, the results of laboratory examination. FGR was diagnosed by a 
delay in fetometry indicators by 2 weeks and more from gestational term. 
Statistical processing of the results was carried out using Statistica 6.0. 
Results of the study. In all clinical groups of the prospective study, patients' ages ranged from 25 
to 40 years, with an average of 31.2 ± 4.3 years in subgroup A, 30.8 ± 4.6 years in subgroup B of the main 
clinical group, and 29.7 ± 3.9 years in pregnant women with physiological gestational course. 
The number of pregnant women who gave birth for the first and second time, as well as the 
number of first-time and second-time pregnant women in all PD subgroups was similar and did not have 
significant differences (p> 0.05). 
In the group of pregnant women with placental dysfunction, the prevalent number of subjects 
(77.1%) gave birth for the first time, only 16 patients (22.9%) gave birth again (without a significant 
difference between subgroups A and B). In the control group, a similar tendency was observed between 
women who gave birth for the first time, 73.3% and repeatedly, 26.7%. 
 In pregnant women in the control group, all pregnancies ended in childbirth within 39 - 41 weeks 
(Table 1). Whereas, the number of preterm births up to 33 + 6 days in pregnant women with manifested PD 
secondary to gestational endotheliopathy reached 17.5%. Premature births in patients of subgroup A in the 
above pregnancy term occurred due to fetal distress in 5 cases (12.5%) and in two (5.0%) because of 
premature placental abruption. 
Table 1. Labor term in women with placental dysfunction secondary to GE (n = 100) 






Relative risk (RR) 
Up to 33+6 days weeks 7 (17.5) - -  
34 - 36+6 days weeks 13 (32.5) 7 (23.3) - RRав 1.39, 95% CI [0.63 
– 3.06], р=0.41.  
Total number of patients 
with preterm birth 
20 (50) 7 (23.3) - RRав 2.14, 95% CI [1.04 
– 4.40], р=0.04. 
37 - 41 weeks 20 (50.0) 23 (76.7) 30 (100)  
Cesarean section 15 (37.5%) 5 (16.7%) 2 (6.7%) RRав 2.25, 95% CI [0.92 
– 5.50], р=0.08. 
RRак 5.62, 95% CI [1.39 
– 22.75], р=0.015. 
RRвк 2.50, 95% CI [0.52 
– 11.89], р=0,25. 
RRавк 4,29, 95% CI 
[1.07 – 17.19], р=0.04. 
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Note - the comparison of groups by the frequency of the case was carried out using exact Fisher test 
(two-sided test). 
During the period of 34-36 + 6 days of pregnancy, the births occurred in 13 patients with fetal growth 
retardation syndrome (32.5%) and in 7 women (23.3%) with pre-nosological form of placental dysfunction. 
However, the difference in this indicator between the clinical study groups was not significant (RR 1.39, 95% 
CI [0.63 - 3.06], p = 0.41). The causes of preterm birth in subgroup A were: premature rupture of fetal 
membranes in 8 cases (20%) and acute fetal distress in 5 (12.5%). In patients with pre-clinical PD, the causes 
of preterm delivery were: PRFM in 2 patients (6.7%) and in 5 (16.7%) acute fetal distress. By the total 
number of preterm births, we noted a significant increase in the indicated index in patients with FGR 
compared with the non-manifested form of PD (RR 2.14, 95% CI [1.04 - 4.40], p = 0.04). 
It should also be noted that the number of cases of caesarean section (CS) reached 15 patients 
(37.5%) in the subgroup of pregnant women with manifested PD and had a significant difference compared 
with pregnant women with physiological gestational course, RR 5.62, 95% CI [1.39 - 22.75], p = 0.015 
(Table 1). According to the case index of the patient from group B, there was no reliable result either for 
women from the control group (p = 0.25) or for patients with FGR (p = 0.08). However, the total number of 
cases of caesarean section in pregnant women with placental dysfunction outweighed the same in women 
with physiological gestational course, RR 4.29, 95% CI [1.07 - 17.19], p = 0.04. 
Cases of acute fetal distress in childbirth were diagnosed in 45% of patients with clinically 
manifested placental dysfunction, and significantly more prevalent in the population of pregnant 
women with preclinical PD (13.3%), RR 3.37, 95% CI [1.27-8.94], p = 0.014. There were no cases of 
acute fetal distress in women with a physiological pregnancy. 
Bleeding in labor was diagnosed in 3 pregnant women (7.5%) from clinical subgroup A. In 
clinical subgroup B, the above complication was diagnosed only in 1 case (3.3%), RR 2.25, 95% CI 
[0.25- 20.57], p = 0.47. 
Afterbirth defect was determined in 8 cases (20%) in patients with fetal growth retardation 
syndrome, in 3 women of subgroup B (10%), RR 2.0, 95% CI [0.58-6.91], p = 0, 27. The overall RR index 
for the presence of afterbirth defect between the clinical study group and women with physiological 
pregnancy was 4.29, 95% CI [0.57-32.01], p = 0.16, and had no statistically significant difference. 
The aforementioned premature rupture of the fetal membranes was registered in 14 pregnant 
women with FGR (35%) and in 7 women with asymptomatic form of placental dysfunction (23.3%), 
RR 1.50, 95% CI [0.69-3.25], p = 0.30. Generalized indicator for the presence of PRFM between 
patients with PD secondary to gestational endotheliopathy and pregnant women from the control 
group was 3.00, 95% CI [0.97-9.30], p = 0.06. 
Assessment of cases of labor abnormalities (LA) showed a rather large number of these disorders 
in women whose pregnancy was complicated by placental dysfunction. 15 pregnant women with 
manifested PD (37.5%) were found to have uterine inertia, mainly in the first period of labor, whereas the 
above mentioned abnormality was noted in 8 cases (26.7%), RR 1.41, 95% CI [0.69-2.88], p = 0.35. When 
comparing the number of LA cases between pregnant PD patients and controls (practically healthy 
women), we found a significant difference in outcomes, RS 3.29, 95% CI [1.07-10.12], p = 0.04. 
Pregnant women, who were involved in our prospective study, gave birth to 100 children 
(Table 2). Due to personification of the risk of development of perinatal pathology, we not only 
managed to avoid cases of antenatal mortality, but also to prevent intranatal and early neonatal losses 
in patients with placental dysfunction secondary to gestational pathology (constant monitoring of 
intrauterine scan, pregnancy, severe restrictions on the use of medicines). The ratio of boys to girls 
was approximately the same in all study groups. The growth rate of newborns among patients in 
clinical subgroup A was 47.3 ± 2.4 cm, on average, while in women with preclinical PD it was 48.9 ± 
1.8 cm (Table 2). We found no statistically significant difference in the sex and growth rates of 
newborns in patients with placental insufficiency and women with physiological pregnancy (p> 0.05). 
Table 2. Functional evaluation of newborns from pregnant women with placental insufficiency 
secondary to gestational endotheliopathy, (n=100) 
Labor term Subgroup А (n= 40) Subgroup В (n= 30) Control group, n=30 
Height, cm 47.3 ± 2.4 48.9 ± 1.8 50.14 ± 0.8 
Weight, g 2724.2 ± 284.5* 3184.8 ± 170.0 3559.5 ± 152.8 
APGAR score during the 
1st min, points 
5.79 ± 1.3* 6.82 ± 0.7 7.90 ± 0.3 
APGAR score during the 
5th min, points 
6.85 ± 1.0* 7.75 ± 0.7 8.86 ± 0.4 
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Note - the comparison of groups by the frequency of the case was carried out using exact Fisher test 
(two-sided test). 
Children born from pregnant women with FGR, which seemed quite logical, had the weight 
within 2724.2 ± 284.5 g, which was significantly less (p <0.05) than the weight of newborns from 
women with uncomplicated pregnancy (3559.5 ± 152.8 g). All newborns in the control group were 
born in a satisfactory condition, 26 infants (86.7%) were born with an APGAR score of 8/9 points, 4 
children (13.3%) with a score of 7/9 points. Neonates born from pregnant patients from subgroup A 
had a significantly lower (p <0.05) APGAR score, both at 5.79 ± 1.3 points at the 1st minute and 6.85 
at the 5th minute. ± 1.0 points, relative to similar indicators of women in the control group. Whereas 
children born to patients with pre-nosological PD had a lower score on the assessment of the condition 
of the child at the 1st and 5th minutes compared to women who were physiologically pregnant, but the 
difference did not have statistical significance (p> 0, 05). 
Infants born to women in the control group were not diagnosed with CNS disorders. Perinatal 
disorders were diagnosed in 12 preterm infants (30%) from pregnant women with FGR and in 3 
infants (10%) from women in clinical subgroup B who were also born prematurely, RR 3.0, 95% CI 
[0.93- 9.70], p = 0.07 (Table 3). 
Table 3. Assessment of neonatal disorders in pregnant women with placental insufficiency 
secondary to gestational endotheliopathy, (n = 100) 
Neonatal disorder Subgroup А (n= 40) Subgroup В (n= 30) Control group, n=30 
Perinataal CNS disorders, 
(n/%) 
12 (30.0) 3 (10.0) 0 
Intraventricular 
hemorrhage (n/%) 
6 (15.0) 2 (6.7) 0 
Cephalohematoma (n/%) 6 (15.0) 4 (1.3) 1 (3.3) 
Pre-natal infection, (n/%) 3 (7,5) 0 0 
Note: * * - significant differences between the prospective study groups using exact Fisher's test (two-sided test). 
Intraventricular hemorrhage (IVH) was also more common in children than from mothers who 
had manifested placental dysfunction, compared with a population of pre-nosological PD, RR 2.25, 
95% CI [0.49-10.38], p = 0.30, although the results were also not statistically significant. 
Cephalohematomas were detected in all study groups, the largest number of them, 6 (15%), 
occurred in newborns whose mothers had fetal growth retardation syndrome but this indicator was not 
significantly higher than in the subgroup of pregnant women with prenatal PD, RR 1.125, 95 % CI 
[0.35-3.64], p = 0.84, and the control group, RR 4.50, 95% CI [0.57-35.43], p = 0.15. 
We also noted that cases of intrauterine infection were observed only in infants born 
prematurely from women of clinical subgroup A, 3 (7.5%). Only 6 (15%) infants of clinical subgroup 
A needed transfer for further treatment to specialized neonatal hospitals. 
Thus, the course of labor and the postpartum period in pregnant women with manifested 
placental dysfunction secondary to gestational endotheliopathy (FGR) was associated with an increase 
in cases of premature birth, RR 2.14, 95% CI [1.04 - 4.40], p = 0.04, indications for abdominal 
operative delivery, RR 5.62, 95% CI [1.39 – 22.75], p = 0.015, cases of acute fetal distress, RR 3.37, 
95% CI [1.27-8.94], p = 0.014, lower infant weight (p <0.05), lower infant APGAR scores (p <0.05) at 
the 1st and 5th minutes. The incidence of adverse perinatal outcomes was higher among newborns 
whose mother was diagnosed with FGR secondary to endothelial dysfunction. 
Conclusions. PD secondary to GE lead to premature birth, fetal distress, increases the 
percentage of caesarean section, contributes to the delay of fetal growth and weight of infants, 
unsatisfactory infant status and perinatal complications. 
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